Want to see CRD.B full AI Analyst Report?
Top Page
Crawford & Company B
(NYSE:CRD.B)
Select Model
Select Model
Rating:55Neutral
Price Target:
$10.50
▲(3.86% Upside)
Action:Reiterated
Date:08/04/26
The score is primarily constrained by weaker recent fundamentals (sharp TTM revenue decline and margin compression) and a relatively expensive valuation (P/E ~30). Technicals are broadly neutral with price slightly above key moving averages, and solid absolute cash flow helps offset some of the near-term earnings pressure.
Positive Factors
Cash generation
Consistently strong trailing‑12‑month operating and free cash flow near reported earnings provides durable internal funding for operations, capex, dividends and debt service. Reliable cash conversion reduces reliance on external financing and supports strategic flexibility across underwriting cycles.
Negative Factors
Sharp revenue decline
A roughly 35% TTM revenue drop is a durable headwind: loss of scale can erode pricing power, increase per‑unit fixed costs and complicate long‑term planning. Sustained top‑line weakness strains margin recovery and makes reinstating prior profitability levels harder without structural strategy changes.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistently strong trailing‑12‑month operating and free cash flow near reported earnings provides durable internal funding for operations, capex, dividends and debt service. Reliable cash conversion reduces reliance on external financing and supports strategic flexibility across underwriting cycles.
Read all positive factors
Crawford & Company B (CRD.B) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$630.46M
Dividend Yield2.45%
Average Volume (3M)4.97K
Price to Earnings (P/E)27.7
Beta (1Y)1.00
Revenue Growth-4.12%
EPS Growth-20.24%
CountryUS
Employees9,943
SectorFinancial
Sector Strength70
IndustryInsurance - Brokers
Share Statistics
EPS (TTM)0.48
Shares Outstanding18,908,806
10 Day Avg. Volume4,431
30 Day Avg. Volume4,969
Financial Highlights & Ratios
PEG Ratio-1.08
Price to Book (P/B)3.22
Price to Sales (P/S)0.42
P/FCF Ratio5.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.96
Revenue Forecast (FY)$1.28B
Crawford & Company B Business Overview & Revenue Model
Company Description
Crawford & Company operates as a global provider of claims management and outsourcing solutions for insurance carriers, brokers, and various corporations. The company's reach extends across the United States, the United Kingdom, Europe, Canada, Au...
How the Company Makes Money
null...
Crawford & Company B Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
56
Neutral
Cash Flow
64
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.29B | 1.31B | 1.34B | 1.32B | 1.23B | 1.14B |
| Gross Profit | 328.33M | 321.90M | 367.55M | 359.07M | 306.35M | 291.80M |
| EBITDA | 93.08M | 92.62M | 97.61M | 102.91M | 52.11M | 91.02M |
| Net Income | 23.52M | 19.63M | 26.60M | 30.61M | -18.30M | 30.69M |
Balance Sheet | ||||||
| Total Assets | 758.25M | 764.30M | 803.75M | 799.20M | 791.51M | 852.64M |
| Cash, Cash Equivalents and Short-Term Investments | 69.42M | 64.08M | 55.41M | 58.36M | 46.01M | 53.23M |
| Total Debt | 270.67M | 270.27M | 309.49M | 311.53M | 346.40M | 288.67M |
| Total Liabilities | 573.73M | 592.87M | 648.20M | 659.37M | 668.13M | 641.24M |
| Stockholders Equity | 186.40M | 173.09M | 157.21M | 141.62M | 124.54M | 211.97M |
Cash Flow | ||||||
| Free Cash Flow | 99.30M | 94.83M | 9.97M | 67.19M | -6.96M | 23.37M |
| Operating Cash Flow | 103.91M | 101.85M | 51.62M | 103.79M | 27.63M | 54.32M |
| Investing Cash Flow | -27.61M | -36.21M | -41.65M | -36.60M | -57.88M | -70.83M |
| Financing Cash Flow | -61.15M | -57.62M | -12.86M | -54.68M | 25.94M | 24.66M |
Crawford & Company B Risk Analysis
Crawford & Company B disclosed 24 risk factors in its most recent earnings report. Crawford & Company B reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Crawford & Company B Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $630.46M | 27.69 | 13.01% | 2.73% | -4.12% | -20.24% | |
56 Neutral | $128.52M | 7.37 | 15.28% | ― | 10.29% | ― | |
55 Neutral | $630.46M | 27.69 | 13.01% | 2.97% | -4.12% | -20.24% | |
51 Neutral | $39.08M | -1.47 | 3.57% | ― | -8.37% | -220.33% |
* Financial Sector Average
CRD.B
Crawford & Company B
12.47
2.94
30.78%
CRD.A
Crawford & Company A
13.29
3.58
36.94%
EHTH
Ehealth
1.22
-2.34
-65.73%
SLQT
SelectQuote
0.73
-1.27
-63.60%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.